{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:50:41Z","timestamp":1747155041037,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ancard.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T07:33:14Z","timestamp":1538465594000},"page":"300-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["D\u00e9pistage de l\u2019hypercholest\u00e9rol\u00e9mie familiale \u00e0 partir du LDL cholest\u00e9rol \u00e0 l\u2019admission en unit\u00e9 de soins intensifs cardiologiques"],"prefix":"10.1016","volume":"67","author":[{"given":"P.","family":"Chemaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Nallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Delarche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Legagneur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Boulestreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Reibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Palette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Courtade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Beaune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-2220","authenticated-orcid":false,"given":"J.-L.","family":"Georges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2018.08.011_bib0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ancard.2018.08.011_bib0145","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ancard.2018.08.011_bib0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.lpm.2013.01.053","article-title":"Diagnostic et traitement des hypercholest\u00e9rol\u00e9mies familiales (HF) chez l\u2019adulte\u00a0: recommandations de la nouvelle soci\u00e9t\u00e9 fran\u00e7aise d\u2019ath\u00e9roscl\u00e9rose (NSFA)","volume":"42","author":"Farnier","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0160","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016\u00a0ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2018.08.011_bib0165","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ancard.2018.08.011_bib0170","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"year":"2011","series-title":"Familial hyper-cholesterolemia cardiologist and patient needs assessment. Survey conducted November 2011","author":"American College of Cardiology CardioSurve","key":"10.1016\/j.ancard.2018.08.011_bib0175"},{"key":"10.1016\/j.ancard.2018.08.011_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ancard.2017.04.015","article-title":"Hypercholest\u00e9rol\u00e9mie familiale\u00a0: un risque cardiovasculaire largement sous-estim\u00e9","volume":"67","author":"Ferri\u00e8res","year":"2018","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.ancard.2018.08.011_bib0185","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10557-016-6685-y","article-title":"Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia and LDL-C of 160mg\/dl or higher","volume":"30","author":"Ginsberg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ancard.2018.08.011_bib0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jacl.2015.07.005","article-title":"Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit","volume":"9","author":"Pang","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ancard.2018.08.011_bib0205","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/eurheartj\/ehv289","article-title":"Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes","volume":"36","author":"Nanchen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2018.08.011_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2004-822984","article-title":"Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia","volume":"4","author":"van Aalst-Cohen","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2004-822987","article-title":"Advanced method for the identification of patients with inherited hypercholesterolemia","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.ancard.2018.08.011_bib0220","doi-asserted-by":"crossref","first-page":"E1811","DOI":"10.1002\/humu.21348","article-title":"Molecular spectrum of autosomal dominant hypercholesterolemia in France","volume":"31","author":"Marduel","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ancard.2018.08.011_bib0225","first-page":"14","article-title":"L\u2019hypercholest\u00e9rol\u00e9mie familiale\u00a0: un diagnostic \u00e0 ne pas manquer en cardiologie","volume":"261","author":"Durlach","year":"2017","journal-title":"Arch Mal C\u0153ur Vaiss Prat"},{"key":"10.1016\/j.ancard.2018.08.011_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ancard.2018.08.011_bib0235","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","author":"Sans auteur","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ancard.2018.08.011_bib0240","first-page":"530","article-title":"Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol","volume":"13","author":"Goldberg","year":"2007","journal-title":"Am J Manag Care"},{"year":"2018","series-title":"Enqu\u00eate sur le cholest\u00e9rol chez le coronarien. R\u00e9sultats de l\u2019enqu\u00eate","author":"Coll\u00e8ge national des cardiologues des h\u00f4pitaux","key":"10.1016\/j.ancard.2018.08.011_bib0245"},{"key":"10.1016\/j.ancard.2018.08.011_bib0250","first-page":"33","article-title":"Le cardiologue et l\u2019hypercholest\u00e9rol\u00e9mie familiale","volume":"43","author":"Nallet","year":"2017","journal-title":"CardioH"},{"year":"2017","series-title":"Principales dyslipid\u00e9mies\u00a0: strat\u00e9gies de prise en charge","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.ancard.2018.08.011_bib0255"},{"key":"10.1016\/j.ancard.2018.08.011_bib0260","unstructured":"European Medicines Agency (EMA). http:\/\/www.ema.europa.eu\/docs\/fr_FR\/document_library\/EPAR_-_Product_Information\/human\/003766\/WC500191398.pdf."},{"journal-title":"JORF","article-title":"Arr\u00eat\u00e9 du 19\u00a0janvier 2018\u00a0modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux","year":"2018","key":"10.1016\/j.ancard.2018.08.011_bib0265"},{"journal-title":"JORF","article-title":"Arr\u00eat\u00e9 du 13\u00a0f\u00e9vrier 2018\u00a0modifiant la liste des sp\u00e9cialit\u00e9s pharmaceutiques remboursables aux assur\u00e9s sociaux","year":"2018","key":"10.1016\/j.ancard.2018.08.011_bib0135"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818301112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392818301112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T10:06:08Z","timestamp":1542017168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392818301112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0003392818301112"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2018.08.011","relation":{},"ISSN":["0003-3928"],"issn-type":[{"type":"print","value":"0003-3928"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9pistage de l\u2019hypercholest\u00e9rol\u00e9mie familiale \u00e0 partir du LDL cholest\u00e9rol \u00e0 l\u2019admission en unit\u00e9 de soins intensifs cardiologiques","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}